UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012456
Receipt number R000014580
Scientific Title Preoperative gemcitabine plus nab-paclitaxel, concurrent 3D conformal radiation therapy for borderline resectable pancreatic cancer: Phase I study
Date of disclosure of the study information 2013/12/03
Last modified on 2017/06/14 17:57:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Preoperative gemcitabine plus nab-paclitaxel, concurrent 3D conformal radiation therapy for borderline resectable pancreatic cancer: Phase I study

Acronym

GEM/nabPTX CRT for BR pancreatic cancer

Scientific Title

Preoperative gemcitabine plus nab-paclitaxel, concurrent 3D conformal radiation therapy for borderline resectable pancreatic cancer: Phase I study

Scientific Title:Acronym

GEM/nabPTX CRT for BR pancreatic cancer

Region

Japan


Condition

Condition

pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The trial objectives is to identify the maximum-tolerated dose (MTD) of gemcitabine plus nab-paclitaxel and concurrent radiation therapy for borderline resectable pancreatic cancer in the setting of preoperative treatment sequence.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Safety

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Induction chemotherapy with GEM/n-P followed by GEM/n-P CRT.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

(1)Patients with BR pancreatic cancer involving 180 degree of less of the circumference of the SMA, CA, or CHA.
(2)Performance Status (ECOG): 0 or 1
(3)Adequate bone marrow reserves, liver/renal functions:
WBC: >=3500/mm3, =<;12000/mm3
Neutrophil: >=1500/mm3
Platelet: >=100000/mm3
Hb: >=9.5g/dL
AST, ALT, AL-P: less than twofold of the upper limit of normal range
T-Bil: =<1.5mg/dL
Cr: =<1.2mg/dL
CCr: >=50ml/min
PaO2: >=70torr
(4)Life expectancy more than 6 months
(5)Written informed consent

Key exclusion criteria

(1)evident infection
(2)Lung fibrosis or intestinal pneumonia, and anamnesis or imaging findings.
(3)Severe complication(liver cirrhosis, uncontrolled diabetes etc)
(4)the onset of myocardial infarction within 3 months
(5)active synchronous malignancy
(6) Pregnant or lactation women, or women with known or suspected pregnancy and men who want let to pregnancy
(7)history of severe drug allergy
(8)neuropathy
(9)patients who are judged inappropriate for the entry of the trial by the investigators

Target sample size

42


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hidenori Takahashi

Organization

Osaka Medical Center for Cancer and Cardiovascular Diseases

Division name

Gastroenterological Surgery

Zip code


Address

1-3-3, Nakamichi, Higashinari-ku, Osaka city, Japan

TEL

+81-6-6972-1181

Email

takahasi-hi@mc.pref.osaka.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hidenori Takahashi

Organization

Osaka Medical Center for Cancer and Cardiovascular Diseases

Division name

Gastroenterological Surgery

Zip code


Address

1-3-3, Nakamichi, Higashinari-ku, Osaka city, Japan

TEL

+81-6-6972-1181

Homepage URL


Email

takahasi-hi@mc.pref.osaka.jp


Sponsor or person

Institute

Department of Gastroenterological Surgery, Osaka Medical Center for Cancer & Cardiovascular Diseases

Institute

Department

Personal name



Funding Source

Organization

Department of Gastroenterological Surgery, Osaka Medical Center for Cancer & Cardiovascular Diseases

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 12 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 09 Month 25 Day

Date of IRB


Anticipated trial start date

2013 Year 12 Month 03 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 12 Month 02 Day

Last modified on

2017 Year 06 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014580


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name